Ilosure 6mg Tablet contains Iloperidone, an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults. Iloperidone exerts its therapeutic effects primarily through antagonism of dopamine D2 and serotonin 5-HT2A receptors, which helps to restore the balance of neurotransmitters in the brain. This medication is effective in reducing both positive symptoms, such as hallucinations and delusions, and negative symptoms, including social withdrawal and apathy. Ilosure 6mg Tablet is administered orally and should be taken as prescribed by a healthcare professional, typically starting with a low dose and gradually titrated to minimize side effects. Common adverse effects may include dizziness, dry mouth, fatigue, and orthostatic hypotension; therefore, patients should be monitored for signs of cardiovascular effects, especially during dose escalation. It is contraindicated in individuals with known hypersensitivity to Iloperidone or its components. Caution is advised in patients with a history of cardiac arrhythmias or QT prolongation. Regular follow-up is necessary to assess therapeutic response and tolerability. Ilosure 6mg Tablet should be used as part of a comprehensive treatment plan including psychosocial interventions. Patients should avoid abrupt discontinuation to prevent withdrawal symptoms or relapse.